Laudanosine restricts Ebola virus entry by targeting TPC2-dependent endolysosomal trafficking
Seitz, T.; Koengeter, J.; Klute, S.; Kraft, F.; Clesle, D. C.; Tschampel, L.; Preising, N.; Rodriguez Alfonso, A. A.; Wiese, S.; Ständker, L.; Jung, C.; Jacob, T.; Köhler, J.; Weidinger, G.; Biedenkopf, N.; Sparrer, K. M. J.; Kirchhoff, F.; Zech, F.
Show abstract
Late endosome-dependent viruses, including filo- and arenaviruses, rely on host endolysosomal trafficking for productive infection. Here, we used a dual-colour Vesicular stomatitis virus (VSV) based pseudoparticle screen of CytoSorb-derived fractions to identify inhibitors of the Zaire Ebolavirus glycoprotein (GP)-mediated entry. Iterative chromatographic purification and mass spectrometry identified Laudanosine, a degradation product of the clinically used neuromuscular blocker Atracurium, as the antiviral compound. Laudanosine specifically inhibited entry mediated by Ebola, Marburg, Lymphocytic choriomeningitis and Lassa virus glycoproteins without affecting VSV-G-dependent entry. Importantly, Laudanosine inhibited authentic Ebola virus infection without detectable cytotoxicity in cell culture and embryonic zebrafish. Molecular dynamics simulations suggest stable association of Laudanosine with the allosteric inhibitory pocket of the lysosomal two-pore channel (TPC2). Consistently, Laudanosine impairs autophagic flux and disrupts endolysosomal trafficking. Together, our findings identify Laudanosine as a previously unrecognised inhibitor of TPC2-dependent entry of highly lethal viral pathogens.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Large scale discovery of coronavirus-host factor protein interaction motifs reveals SARS-CoV-2 specific mechanisms and vulnerabilities 95%
- Enhancing Intracellular Accumulation and Target Engagement of PROTACs with Reversible Covalent Chemistry 95%
- Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function 95%
Similar papers in this journal
- Inhibitors of the Small Membrane (M) Protein Viroporin Prevent Zika Virus Infection 96%
- A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus 95%
- Protein-lipid interaction at low pH induces oligomerisation of the MakA cytotoxin from Vibrio cholerae 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.